These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 16673500

  • 1. Debate over warnings for ADHD stimulants.
    Child Health Alert; 2006 Apr; 24():1. PubMed ID: 16673500
    [No Abstract] [Full Text] [Related]

  • 2. ADHD drugs and cardiovascular risk.
    Rappley MD, Moore JW, Dokken D.
    N Engl J Med; 2006 May 25; 354(21):2296-8; author reply 2296-8. PubMed ID: 16729375
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cardiovascular safety of medication treatments for attention-deficit/hyperactivity disorder.
    Newcorn JH, Donnelly C.
    Mt Sinai J Med; 2009 Apr 25; 76(2):198-203. PubMed ID: 19306385
    [No Abstract] [Full Text] [Related]

  • 6. ADHD drugs and cardiovascular risk.
    Anders T, Sharfstein S.
    N Engl J Med; 2006 May 25; 354(21):2296-8; author reply 2296-8. PubMed ID: 16723628
    [No Abstract] [Full Text] [Related]

  • 7. Recent developments in direct consumer advertising of attention disorder stimulants and creating limits to withstand constitutional scrutiny.
    Strawn MN.
    J Contemp Health Law Policy; 2003 May 25; 19(2):495-520. PubMed ID: 14748255
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA, Pliszka SR.
    Pharmacotherapy; 2009 Jun 25; 29(6):656-79. PubMed ID: 19476419
    [Abstract] [Full Text] [Related]

  • 10. Stimulant treatment of ADHD and risk of sudden death in children.
    Vitiello B, Towbin K.
    Am J Psychiatry; 2009 Sep 25; 166(9):955-7. PubMed ID: 19528196
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Stimulant-drug therapy for attention-deficit disorder (with or without hyperactivity) and sudden cardiac death.
    Knight M.
    Pediatrics; 2007 Jan 25; 119(1):154-5. PubMed ID: 17200281
    [No Abstract] [Full Text] [Related]

  • 13. With the recent Food and Drug Administration (FDA) Advisory Committee's recommendation to put a black box warning on stimulants, the government has joined the media in raising alarm about the medical treatment of attention-deficit disorder.
    Hackford R.
    J Dev Behav Pediatr; 2006 Apr 25; 27(2):179. PubMed ID: 16682886
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clip & save: drug chart. FDA-approved drugs to treat ADHD.
    J Psychosoc Nurs Ment Health Serv; 2010 Mar 25; 48(3):9-10. PubMed ID: 20302260
    [No Abstract] [Full Text] [Related]

  • 18. ADHD treatment and the risk of substance abuse.
    Sircy RA, Stojanoski A.
    Nurse Pract; 2008 Apr 25; 33(4):33-6. PubMed ID: 18388552
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.